TABLE I.
Test agent | CAS. No. | Vehicle | Treatment schedule | Dose level (mg/kg/day) | Rationale for top dose level |
---|---|---|---|---|---|
Aristolochic acids I/II | 313–67–7 | PBS | 3 days × 1 cycle 3 days × 3 cycles |
0, 5.5, 11, 22 0, 5.5, 11, 22 |
From literature, Bhalli et al. (2013) |
Benzo[a]pyrene | 50–32-8 | Sesame oil | 3 days × 1 cycle 3 days × 3 cycles |
0, 62.5, 125, 250 0, 62.5, 125, 250 |
From literature, Phonethepswath et al. (2010) |
Cisplatin | 15663–27-1 | 0.9% Saline | 3 days × 1 cycle 3 days × 3 cycles |
0, 0.5, 1, 2 0, 0.5, 1, 2 |
Preliminary dose range finding study |
Cyclophosphamide monohydrate | 6055–19–2 | Water | 3 days × 1 cycle 3 days × 3 cycles |
0, 3.75, 7.5, 15 0, 3.75, 7.5, 15 |
From literature, Dertinger et al. (2012) |
Diethylnitrosamine | 55–18–5 | Water | 3 days × 1 cycle 3 days × 3 cycles |
0, 10, 20, 40 0, 10, 20, 40 |
From literature, Avlasevich et al. (2018) |
1,2-Dimethylhydrazine-2HCl | 306–37–6 | Water | 3 days × 1 cycle 3 days × 3 cycles |
0, 7.5, 15, 30 0, 7.5, 15, 30 |
Preliminary dose range finding study |
Dimethylnitrosamine | 62–75–9 | 0.5% Methyl cellulose | 3 days × 1 cycle 3 days × 3 cycles |
0, 2.5, 5, 10 0, 2.5, 5, 10* |
Preliminary dose range finding study |
2,6-Dinitrotoluene | 606–20–2 | Sesame oil | 3 days × 1 cycle 3 days × 3 cycles |
0, 25, 50, 100 0, 25, 50, 100 |
Preliminary dose range finding study |
Hydroxyurea | 127–07–1 | Water | 3 days × 1 cycle 3 days × 3 cycles |
0, 31.25, 62.5, 125 0, 31.25, 62.5, 125 |
From literature, Dertinger et al. (2012) |
Melphalan | 148–82–3 | Sesame oil | 3 days × 1 cycle 3 days × 3 cycles |
0, 0.375, 0.75, 1.5 0, 0.75, 1.5, 3 |
From literature, Dertinger et al. (2012) |
Temozolomide | 85622–93–1 | 0.5% Methyl cellulose | 3 days × 1 cycle 3 days × 3 cycles |
0, 3.75, 7.5, 15 0, 3.75, 7.5, 15 |
Preliminary dose range finding study |
Quinoline | 91–22–5 | Sesame oil | 3 days × 1 cycle 3 days × 3 cycles |
0, 75, 100, 125 0, 75, 100, 125 |
From literature, Avlasevich et al. (2018) |
Vinblastine sulfate | 143–67–9 | 0.9% Saline | 3 days × 1 cycle 3 days × 3 cycles |
0, 0.0625, 0.125, 0.25 0, 0.075, 0.125, 0.175 |
Preliminary dose range finding study |